Youcare Pharmaceutical Group Co., Ltd.

688658

CNE100005XQ2

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-15 pm EDT			5-day change	1st Jan Change
17.06 ^CNY	+0.59%		-1.95%	-18.22%

Apr. 29	Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 09	Youcare Pharma Gets Nod for Registration of Gastric Drug	MT

Youcare Pharmaceutical Group Co., Ltd.(XSSC:688658) added to S&P Global BMI Index

September 18, 2023 at 12:00 am EDT

Latest news about Youcare Pharmaceutical Group Co., Ltd.

Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Youcare Pharma Gets Nod for Registration of Gastric Drug	Apr. 09	MT
Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
Youcare Pharmaceutical’s Antibiotic Passes Generic Drug Evaluation	Jan. 25	MT
Tranche Update on Youcare Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on June 25, 2023.	Jan. 03	CI
Certain A Shares of Youcare Pharmaceutical Group Co., Ltd. are subject to a Lock-Up Agreement Ending on 24-DEC-2023.	Dec. 23	CI
Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Tranche Update on Youcare Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on June 25, 2023.	23-10-08	CI
Youcare Pharmaceutical Group Co., Ltd.(XSSC:688658) added to S&P Global BMI Index	23-09-18	CI
Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17	CI
Youcare Pharma's Cefoperazone Sodium Sulbactam Sodium for Injection Passes Regulatory Evaluation	23-08-09	MT
Tranche Update on Youcare Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on June 25, 2023.	23-07-04	CI
Youcare Pharma to Repurchase Up to 200 Million Yuan Shares	23-06-26	MT
Youcare Pharmaceutical Group Co., Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.	23-06-25	CI
Youcare Pharmaceutical Group Co., Ltd. authorizes a Buyback Plan.	23-06-24	CI
Youcare Pharma’s Inhaled COVID-19 Drug Candidate Cleared For Clinical Trial in Australia	23-05-24	MT
Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI

Chart Youcare Pharmaceutical Group Co., Ltd.

Duration

Period

Chart Youcare Pharmaceutical Group Co., Ltd.

More charts

Youcare Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the development and production of chemical drugs. The Companyâs products are mainly cardiovascular and cerebrovascular drugs, digestive system drugs, diabetes drugs and anti-infective drugs, including ginkgo biloba extract injection, gastrodin injection, lansoprazole for injection, and omeprazole enteric-coated capsules , metformin hydrochloride sustained-release tablets, cefuroxime sodium for injection and ceftriaxone sodium for injection, etc. The Company conducts its businesses within the China market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-22 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

17.06 CNY

Average target price

28 CNY

Spread / Average Target

+64.13%

Consensus

Annual profits - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
YOUCARE PHARMACEUTICAL GROUP CO., LTD.	-18.22%	1.06B
KYOWA KIRIN CO. LTD.	+10.23%	9.11B
SK BIOPHARMACEUTICALS CO., LTD.	-10.76%	5.21B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+53.60%	4.83B
YUHAN CORPORATION	+7.56%	4.09B
BETTA PHARMACEUTICALS CO., LTD.	-21.42%	2.35B
INDIVIOR PLC	+14.43%	2.32B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+25.03%	2.27B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-30.36%	2.19B
VELOXIS PHARMACEUTICALS A/S	-0.50%	1.64B

Specialty & Advanced Pharmaceuticals